Application of a genetic signature of late GU toxicity in SCIMITAR, a Post-op SBRT trial.
Clin Transl Radiat Oncol
; 39: 100594, 2023 Mar.
Article
em En
| MEDLINE
| ID: mdl-36880064
Predictors of genitourinary toxicity after post-prostatectomy radiotherapy remain elusive. A previously defined germline DNA signature (PROSTOX) has shown predictive ability for late grade ≥ 2 GU toxicity after intact prostate stereotactic body radiotherapy. We explore whether PROSTOX would predict toxicity among patients receiving post-prostatectomy SBRT on a phase II clinical trial.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Revista:
Clin Transl Radiat Oncol
Ano de publicação:
2023
Tipo de documento:
Article
País de afiliação:
Estados Unidos